Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Slides:



Advertisements
Similar presentations
Evaluation of Oral Azacitidine Using Extended Treatment Schedules: A Phase I Study Garcia-Manero G et al. Proc ASH 2010;Abstract 603.
Advertisements

Emergency Care Part 1: Managing Diabetic Ketoacidosis (DKA)
1. 2 ACEI inhibit angiotensin converting enzyme in the body. ACEI inhibit angiotensin converting enzyme in the body. Enzyme maintains balance between:
Joanna Prickett North Bristol NHS Trust
Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory Odette Cancer Centre.
Diabetes in Schools Reviewing the New Laws Diane Stewart APN-C, CDE.
Update on Imaging: Detection of Iron in Liver and Heart Tim St. Pierre, BSc, PhD Professor School of Physics The University of Western Australia Crawley,
ANEMIA IN PREGNANCY O+G Update 2014 Hospital Sarikei.
Update of Anemia management in chronic kidney disease What is still missing.
Current Treatment Options in MDS Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory Odette Cancer Centre.
1 Rash and Low T2* MRI in a Paediatric Thalassaemia Patient.
Slide 1 of 16 Dose Titration in a Patient with Myelodysplastic Syndromes.
Liver Disease and Thalassaemia George Constantinou.
HEREDITARY HAEMOCHROMATOSIS. What Is It? An inherited disease characterised by excess iron deposition in various organs Leads to eventual fibrosis and.
QUANTITATIVE IMAGING OF HUMAN LIVER IRON CONCENTRATIONS IN VIVO
Chapter Seven - Part Two The Trace Minerals & Water Food & Nutritional Health NUT SCI –242 Karen Lacey, MS, RD, CD © Spring 2005.
Managing Iron Overload in Beta Thalassemia Major: Focus on Cardiac Iron Ali Taher, MD American University of Beirut Lebanon.
Dr. Sarah Zahid PHARMACOLOGICAL MANAGEMENT OF IRON DEFICIENCY ANEMIA.
iron overload in haemoglobinopathies
Liver & Pancreas Afflictions. Jaundice: common symptom of liver damage. Causes yellowing of skin and eyes due to excess bilirubin (red blood cell breakdown.
Iron Toxicity. Overview Principle of the disease Clinical features Diagnosis management.
Clinical aspects of Maternal and Child Nursing NUR 363 Lecture 8.
Hepatitis By: Mst Tabassum. History Early case in the 18 th century By 1885, it was showed to be transmittable through blood transfusion and syringes.
INTRODUCTION Although iron poisoning is the most common cause of death due to poisoning in young children, it is also a significant problem in adolescents.
Iron Metabolism HMIM224.
Michael Dickinson, Haematologist
 Ali Taher,1 Chaim Hershko2 and Maria Domenica Cappellini.
Noncompliance with Iron Chelation Therapy in an Adolescent with Thalassaemia Major Adlette C. Inati, MD Head, Division of Pediatric Hematology-Oncology.
Side effects. Side effects: Isoniazid Rash, abnormal liver function, hepatitis, peripheral neuropathy and mild central nervous system (CNS) effects. Hepatitis.
Diabetic Ketoacidosis DKA)
1. IRON METABOLISM INTRODUCTORY BACKGROUND Essential element in all living cells Transports and stores oxygen Integral part of many enzymes Usually bound.
Efficacy and Safety of Deferasirox (Exjade®) during 1 Year of Treatment in Transfusion-Dependent Patients with Myelodysplastic Syndromes: Results from.
Thalassemia Workshop: Chelation Therapy Chi-Kong Li, MBBS, MD Department of Paediatrics Prince of Wales Hospital The Chinese University of Hong Kong BTG.
oral hypoglycemic agents
Clinical Considerations for Managing Iron Overload in MDS: Analysis From EHA Aristoteles Giagounidis, MD, PhD Associate Professor of Medicine Head, Hematology/Oncology.
Patient Information - Viral Hepatitis B (HBV)
Mariane de Montalembert, MD
CU-1 Iron Overload: Complications and Need for Therapy John B. Porter, MD Professor of Hematology University College, London, UK.
Dr. Sadia Batool Shahid PGT-M-Phil, Pharmacology
 Stored in the body as ferritin  Deficiency result from negative iron balance due to depletion of stores and/or inadequate intake.  Iron deficiency.
TRACE ELEMENTS IRON. IRON METABOLISM DISTRIBUTION OF IRON IN THE BODY Between 50 to 70 mmol (3 to 4 g) of iron are distributed between body compartments.
CE-1 Exjade ® (deferasirox; ICL670) Efficacy and Safety Peter Marks, MD, PhD Senior Director, Clinical Development Novartis Pharmaceuticals Corporation.
Side effects. Side effects: Isoniazid Rash, abnormal liver function, hepatitis, peripheral neuropathy and mild central nervous system (CNS) effects. Hepatitis.
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
Metabolism of iron Alice Skoumalová. Iron in an organism:  total 3-4 g (2,5 g in hemoglobin)  heme, ferritin, transferrin  two oxidation states: Fe.
AGENTS FOR MEGALOBLASTIC ANEMIAS. Megaloblastic anemia is treated with folic acid and vitamin B12. Folate deficiencies usually occur secondary to increased.
AGENTS USED FOR IRON DEFICIENCY
Nada Mohamed Ahmed, MD, MT (ASCP)i. Definition. Physiology of iron. Causes of iron deficiency. At risk group. Stages of IDA (pathophysiology). Symptoms.
M. Domenica Cappellini, MD
A. Bazrafshan, MD Felloweshipe of Pediatric Hematology-Oncology Shiraz University of Medical Science Shiraz – Iran
Deferasirox in treatment of chronic iron overload
TREATMENT IRON DEFICIENCY ANEMIA. 3 Approaches in the Treatment of IDA: 1.Red Cell Transfusion 2.Oral Iron Therapy 3.Parenteral Iron Therapy Braunwald.
Donepezil. Donepezil Generic name: Donepezil. Brand name: Aricept. Chemistry: Donepezil hydrochloride is a piperidine derivative. It is a white crystalline.
Foundation Knowledge and Skills
Thalassemia Center 1 Iron Overload in Chronic Anaemias.
Exjade One Year Experience Dr Khawla Belhoul Director Thalassemia Center 9 Th February 2008.
Acetaminophen Intoxication Ali Labaf M.D. Assistant professor Department of Emergency Medicine Tehran University of Medical Science.
Lecture 6 TOXICITY Toxicity from excessive dietary intake of major minerals rarely occurs in healthy individuals. Kidneys that are functioning normally.
ROLE OF IRON IN HEALTH AND DISEASE
Acetylcysteine for Acetaminophen Poisoning
Metreleptin Drugbank ID :DB09046
Pharmacology of chelators
IRON IN HEALTH AND DISEASE
oral hypoglycemic agents
Other Protein Synthesis Inhibitor
Iron Overload in Chronic Anaemias
Clinical Case: Managing Iron Overload in a Patient with Transfusion-Independent Thalassaemia Intermedia Ali T. Taher, MD Professor Department of Internal.
Metabolism of iron Alice Skoumalová.
IRON IN HEALTH AND DISEASE Enterocyte Gut ABSORPTION OF IRON Fe+++ Ferritin Fe++ Tf-Fe+++ Fe++ Haem Tf.
Iron overload in Sickle Cell disease
Presentation transcript:

Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory

Preview Why we need iron The iron economy Why too much iron is a bad thing Pumping (out) iron Current recommendations for treatment of iron overload in MDS

Why we need iron Enzymes Oxygen transport –Haemoglobin (red blood cells) –Myoglobin (muscle cells) About 70% of the body’s iron is in these proteins

The iron economy

The iron economy is well- balanced. 70% 30%

We cope well with iron shortage… Iron deficiency is the most common deficiency state in the world –Blood loss –dietary About 1000 mg of iron is stored as ferritin (1/3 of total body iron) Intestinal absorption of iron increases in response to deficiency

…but poorly with iron excess. Iron is excreted by shedding of intestinal cells There is no physiologic mechanism to excrete excessive iron

Blood transfusion overwhelms the iron balance Normal daily iron flux: 1-2 mg Each unit of PRBC: mg

Summary: Iron is in a fine balance In normal circumstances, not much iron enters or leaves the body The body cannot increase its excretion of iron. Blood transfusions contain much iron, so patients who need frequent transfusions will build up excess iron.

Why too much iron is a bad thing

Dying RBC Reticuloendothelial System Free Iron Liver Heart Endocrine organs CIRRHOSIS ARRHYTHMIA HEART FAILURE DIABETES

Lessons from thalassaemia

When does iron become a problem? Normally 2.5 – 3 grams of iron in the body. Tissue damage when total body iron is 7 – 15 grams –After units of red blood cells

How do we know if there’s too much iron? Serum ferritin concentration –Used in clinical practice globally Liver biopsy –Reference methodology (‘gold standard’) Magnetic resonance imaging (MRI) –Investigational, potential for broad access Magnetic susceptometry (SQUID) –Investigational, very limited access

Serum Ferritin Concentration Easy Inexpensive Can be tricky – not purely iron –Inflammation (acute phase reactant) –Liver function abnormalities Not perfect marker in iron overload –What it lacks in accuracy it makes up for in part with world-wide availability

Liver Biopsy LIC = Liver iron concentration. Reprinted with permission from Angelucci E, et al. N Engl J Med. 2000;343: patients with iron overload and cirrhosis  1 mg dry weight liver sample Hepatic iron concentration, mg/g dry weight Total body iron stores, mg/kg r = 0.98 LIC accurately reflects total body iron stores

Magnetic Susceptometry (SQUID) Superconducting QUantum Interference Device –High-power magnetic field –Iron interferes with the field –Changes in the field are detected Noninvasive, sensitive, and accurate Limited availability –Superconductor requires high maintenance –Only 4 machines worldwide Photograph courtesy of A. Piga

Magnetic Resonance Imaging Bright = high iron concentration; dark areas = low iron concentration

Summary: Too much iron is bad Iron overload caused by transfusions causes malfunction of the liver, heart, and endocrine organs. Problems may begin after 30 units of RBC (or even earlier) We use serum ferritin level to estimate iron levels –MRI might be better

Iron chelation Out

Metal Chelator + Toxic Non-Toxic “Chelate” Outside the Body Metal What is Chelation Therapy?

How to chelate? Currently licensed in Canada: –Deferoxamine Alternatives –Deferiprone (L1) Available on compassionate release –Deferasirox (ICL670, Exjade) Undergoing accelerated review by Health Canada

Deferoxamine: Mode of Action

Challenges of Deferoxamine Subcutaneous/Intravenous route of administration –Expensive –Cumbersome –Uncomfortable Rapid metabolism (30 minute half-life) necessitates prolonged infusion (12-15 hours) Complications due to iron overload still occur due to poor compliance with therapy

Deferoxamine infusion

Common Side Effects of Deferoxamine Local reactions –Erythema (localized redness) –Induration (localized swelling) –Pruritus (itchiness) Ophthalmologic –Reduced visual acuity –Impaired color vision –Night blindness –Increased by presence of diabetes Hearing loss Zinc deficiency

Are we certain it helps? Survival of patients with thalassaemia

Summary: Iron chelation and deferoxamine Chelation works by attaching a drug to iron, which allows the body to excrete it. Deferoxamine is awful stuff… –Inconvenient and uncomfortable to take –Many nasty side effects …but it works –Enormous extension of lifespan in thalassaemia.

ICL670: Deferasirox, Exjade n Oral, dispersible tablet n Taken once daily n Highly specific for iron n Chelated iron excreted mainly in faeces n Less than 10% excreted in the urine

ICL670 works. Deferoxamine< ≥ 50 ICL All doses in mg/kg/day  g/L Deferoxamine 0107 ICL ICL

ICL670 is Generally Tolerable n The most common adverse events were mild and transient: –Nausea (10%) –Vomiting (9%) –Abdominal pain (14%) –Diarrhea (12%) –Skin rash (8%) n Rarely required discontinuation of study drug n Mild increases in serum creatinine n No agranulocytosis observed

When can we have Exjade? Already FDA-approved in the USA Health Canada approval expected September 2006 Provincial formularies will need to decide whether to include Exjade.

What do the experts say?

Recommended Treatment for Iron Overload in MDS Why: to prevent end-organ complications of iron overload and extend lifespan Whom: transfusion-dependent patients with expected survival > 1 year When: after 25 units RBC transfused, ferritin >1000. How: Desferal by subcutaneous infusion (for now); keep ferritin<1000

Summary Iron overload is an inevitable consequence of chronic RBC transfusion Iron toxicity affects the function of the liver, heart, and endocrine organs Chelation therapy should be offered to iron overloaded patients with life expectancy >1 year Desferal is the only drug currently available; Exjade will be available soon.

Thank you!